Optical Molecular Tomography for Regenerative Medicine

用于再生医学的光学分子断层扫描

• 批准号: 7774489
• 负责人: SHAY SOKER
• 金额: $ 73.79万
• 依托单位: VIRGINIA POLYTECHNIC INST AND ST UNIV
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-03-01 至 2013-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7774489
• 关键词: Address; Affect; Algorithms; Anastomosis - action; Animals; Area; Arthritis; Bathing; Biological; Biological Assay; Biological Process; Biomedical Engineering; Biomedical Research; Biopsy; Bioreactors; Bladder; Blood Vessels; Blood flow; Cardiovascular Diseases; Carotid Arteries; Cell Line; Cell physiology; Cells; Chronic; Cicatrix; Clinical; Complex; Degenerative Disorder; Development; Diabetes Mellitus; Endothelial Cells; Engineering; Fluorescence; Fluorescent Probes; Gene Expression; Goals; Growth; Hand; Heart; Histology; Human; Hybrids; Image; Imagery; Imaging Device; Immunosuppression; Implant; In Vitro; Inflammation; Kidney; Knowledge; Label; Laboratories; Lasers; Life; Light; Liver; Liver Failure; Measurement; Medical; Medicine; Messenger RNA; Methods; Modeling; Molecular; Monitor; Morphologic artifacts; Natural regeneration; Nervous system structure; Noise; Optical Coherence Tomography; Optical Tomography; Optics; Organ; Organ Transplantation; Organism; Osteoporosis; Pathology; Patients; Performance; Phase; Photons; Physiological; Physiology; Play; Population Dynamics; Prevention; Process; Proteins; Regenerative Medicine; Reporter; Resolution; Risk; Role; Sheep; Skeleton; Smooth Muscle Myocytes; Spinal cord injury; Staging; Stroke; Surface; System; Systems Biology; Techniques; Technology; Testing; Three-Dimensional Image; Three-dimensional analysis; Time; Tissue Engineering; Tissues; Transplantation; Trauma; Tubular formation; United States National Institutes of Health; Vascularization; base; cell motility; cell type; clinical application; clinical practice; design; human disease; image reconstruction; implantation; improved; in vivo; innovation; interest; migration; minimally invasive; molecular imaging; mouse model; nerve supply; nervous system disorder; optical fiber; optical imaging; prototype; public health relevance; reconstruction; repaired; research study; response; scaffold; simulation; tissue phantom; tissue regeneration; tomography

DESCRIPTION (provided by applicant): The most important medical challenges include cardiovascular diseases, stroke, degenerative neurological diseases, diabetes, arthritis, osteoporosis, kidney and liver failure, spinal cord injury, burns, battlefield trauma, and other devastating conditions. Organ transplantation addresses some of these needs, but the scarcity of donors and the risk of immune suppression pose major limitations on transplantation. Regenerative medicine seeks to devise new ways to repair or replace damaged tissues and organs for millions of patients who cannot receive transplants. A core technology is the bioengineering of a functional tissue or organ by seeding living cells onto a biodegradable scaffold and then surgically implanting the construct into a patient. Tissue engineering involves extensive remodeling of cells and scaffolds. A major barrier to progress has been the inability to monitor this dynamic complex biological process in real-time, which makes control and optimization extremely difficult. On the other hand, as defined in the NIH roadmap molecular imaging plays an increasingly important role in the advancement of medicine. The optical molecular imaging tools has now allowed much better understanding of biological interactions at molecular and cellular levels in mouse models of almost all human diseases, and found several major clinical applications. Therefore, we are motivated to integrate these two forefront technologies in biomedical research - tissue engineering and optical molecular imaging - in a single unified framework, and drive a paradigm shift from static assays of cellular function in biopsied tissue or 2D culture models towards systematic analysis of 3D systems. The overall goal of this project is to develop a first-of-its-kind multi-probe multi-modal optical molecular tomography system for regenerative medicine and to demonstrate its utility in assessing the bioengineered blood vessels at the pre- and post-implantation stages. Fluorescent probes will be used to label the tubular scaffold and the two main cell types of blood vessels (endothelial cells lining the lumen, and smooth muscle cells in the wall). Optical fibers embedded within the scaffold will deliver laser light for optical coherence tomography and to excite the fluorescent probes. Innovative algorithms will be developed to reconstruct 3D distributions of multiple fluorescent probes. The proposed imaging system will first be used to track the development of bioengineered vessels in 100¿m resolution in a bioreactor mimicking blood flow conditions. Additional fluorescent probes will be used to monitor cell-specific gene expression and verify physiological responses of cells within the engineered vessel. The vessels will then be implanted as interposition grafts in the carotid arteries of living sheep, and will be imaged in 500¿m resolution to follow the tissue regeneration and function. Successful completion of the project will create new optical molecular imaging tools with a demonstrated application in vessel engineering, and have major and lasting impacts on many other areas in regenerative medicine. PUBLIC HEALTH RELEVANCE: Regenerative medicine creates an organ or tissue by seeding one's own cells onto a biodegradable scaffold and surgically implants it into him/her. Using bioengineered blood vessels as the first example, this project will develop a sophisticated optical imaging system to observe, analyze and optimize the complex processes of tissue regeneration in the laboratory and in live animals. The results will potentially benefit tens of millions of patients suffering from severely damaged vascular or nervous systems, heart, kidneys, liver, skeleton, bladder, or other organs.

描述(由申请人提供)：最重要的医学挑战包括心血管疾病、中风、退行性神经疾病、糖尿病、关节炎、骨质疏松症、肾和肝脏衰竭、脊髓损伤、烧伤、战场创伤和其他破坏性条件。器官移植解决了其中一些需求，但捐赠者的稀缺和免疫抑制的风险对移植构成了主要限制。再生医学寻求为数百万无法接受移植的患者设计新的方法来修复或替换受损的组织和器官。一项核心技术是将活细胞种植到可生物降解的支架上，然后通过手术将结构植入患者体内，从而对功能组织或器官进行生物工程。组织工程涉及细胞和支架的广泛重塑。取得进展的一个主要障碍是无法实时监测这一动态的复杂生物过程，这使得控制和优化变得极其困难。另一方面，正如NIH路线图所定义的那样，分子成像在医学进步中发挥着越来越重要的作用。光学分子成像工具现在可以更好地了解几乎所有人类疾病的小鼠模型在分子和细胞水平上的生物相互作用，并发现了几个主要的临床应用。因此，我们有动力将生物医学研究中的这两项前沿技术--组织工程和光学分子成像--整合到一个统一的框架中，并推动范式转变，从对活组织或2D培养模型中的细胞功能的静态分析转向对3D系统的系统分析。该项目的总体目标是开发一种用于再生医学的首个多探头多模式光学分子断层扫描系统，并展示其在评估植入前和植入后阶段生物工程血管的有效性。荧光探针将被用来标记管状支架和两种主要的血管细胞类型(管腔内的内皮细胞和管壁的平滑肌细胞)。嵌入支架内的光纤将为光学相干层析成像提供激光，并激发荧光探针。将开发创新的算法来重建多个荧光探针的3D分布。建议的成像系统将首先用于在模拟血液流动条件的生物反应器中跟踪100米分辨率的生物工程血管的发育。更多的荧光探针将被用来监测细胞特异性基因表达，并验证工程血管内细胞的生理反应。然后，这些血管将作为间歇性移植物植入活体绵羊的颈动脉，并将以500？m的分辨率进行成像，以跟踪组织的再生和功能。该项目的成功完成将创造新的光学分子成像工具，在血管工程中得到示范应用，并对再生医学的许多其他领域产生重大和持久的影响。 与公共健康相关：再生医学通过将自己的细胞种植到可生物降解的支架上并通过手术将其植入体内来创造器官或组织。以生物工程血管为第一例，该项目将开发一种复杂的光学成像系统，以在实验室和活体动物中观察、分析和优化复杂的组织再生过程。这一结果可能会使数千万患有严重损伤的血管或神经系统、心脏、肾脏、肝脏、骨骼、膀胱或其他器官的患者受益。